Close Menu

NEW YORK — Israeli proteomics firm OncoHost said today that it and its partner RayBiotech have received a $1 million grant from the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation.

The fund will support the companies' development and clinical validation of a test to predict patient response to immunotherapy treatment in non-small cell lung cancer and to develop an automated slide assistance platform to enable large-scale protein processing for host response enrichment work for pharmaceutical companies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.